4/A
Changes in Ownership
Korro Bio, Inc. Filed Acc 0000950170-23-032734
Chief Scientific Officer sold 2,610 shares at an average $0.36 ($953)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loose Christopher R. · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-07 | Sale : show line 1 in the form 10b5-1 | −1,306 | $0.36 | $470 | 203,689 | D |
| 2023-07-10 | Sale : show line 2 in the form 10b5-1 | −1,304 | $0.37 | $482 | 202,385 | D |
| Open-market sales · 2,610 sh · avg $0.36 · $953 | ||||||
Loading xslF345X04/ownership.xml…